KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other Working Capital Changes (2018 - 2025)

Moderna (MRNA) has disclosed Other Working Capital Changes for 8 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 102.93% to -$6.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.0 million through Dec 2025, down 175.0% year-over-year, with the annual reading at -$21.0 million for FY2025, 175.0% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$6.0 million at Moderna, down from -$5.0 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.3 billion in Q4 2023, with the low at -$2.4 billion in Q2 2022.
  • Average Other Working Capital Changes over 5 years is -$146.5 million, with a median of -$5.0 million recorded in 2025.
  • The sharpest move saw Other Working Capital Changes surged 1300.0% in 2021, then plummeted 8090.0% in 2023.
  • Over 5 years, Other Working Capital Changes stood at -$169.0 million in 2021, then crashed by 767.46% to -$1.5 billion in 2022, then skyrocketed by 190.25% to $1.3 billion in 2023, then tumbled by 84.5% to $205.0 million in 2024, then plummeted by 102.93% to -$6.0 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$6.0 million, -$5.0 million, and -$5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.